Atıf Formatları
Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Şansaçar Et Al. , "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells," Medical Oncology , vol.41, no.1, 2024

Şansaçar, M. Et Al. 2024. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical Oncology , vol.41, no.1 .

Şansaçar, M., Sağır, H., & GENCER AKÇOK, E. B., (2024). Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical Oncology , vol.41, no.1.

Şansaçar, MERVE, Helin Sağır, And EMEL BAŞAK GENCER AKÇOK. "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells," Medical Oncology , vol.41, no.1, 2024

Şansaçar, MERVE Et Al. "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells." Medical Oncology , vol.41, no.1, 2024

Şansaçar, M. Sağır, H. And GENCER AKÇOK, E. B. (2024) . "Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells." Medical Oncology , vol.41, no.1.

@article{article, author={MERVE ŞANSAÇAR Et Al. }, title={Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells}, journal={Medical Oncology}, year=2024}